Stem cell mobilization kinetics in elderly patients with multiple myeloma

dc.authoridDogu, Mehmet Hilmi/0000-0001-7237-2637
dc.authoridEREN, Rafet/0000-0003-0973-6279
dc.authoridErkurt, Mehmet Ali/0000-0002-3285-417X
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authoridAltuntas, Fevzi/0000-0001-6872-3780
dc.authorwosidDogu, Mehmet Hilmi/W-2255-2017
dc.authorwosidEREN, Rafet/G-1879-2019
dc.authorwosidErkurt, Mehmet Ali/ABI-7232-2020
dc.authorwosidKAYA, Emin/W-2951-2017
dc.authorwosidAltuntas, Fevzi/E-8945-2015
dc.contributor.authorDogu, Mehmet Hilmi
dc.contributor.authorBatgi, Hikmetullah
dc.contributor.authorErkurt, Mehmet Ali
dc.contributor.authorHacioglu, Sibel
dc.contributor.authorTekgunduz, Emre
dc.contributor.authorKaya, Emin
dc.contributor.authorIskender, Dicle
dc.date.accessioned2024-08-04T20:44:24Z
dc.date.available2024-08-04T20:44:24Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIn this study, we aimed to investigate whether the procedure and product kinetics differ according to age groups in advanced-age MM patients who underwent autologous HSCT. 59 patients who underwent autologous HSCT were retrospectively analyzed. Then, the patients were divided into two groups as 60-65 years and >= 65 years. It was significantly lower in >= 65 years group (p=0.008) and proportionally, the procedure duration was also significantly shortened in this group (p=0.013). Total number of collected CD34 positive stem cells was 6.20 x 106 (+/- 3.83) in 60-65 years group while it was 5.51 x 106 (+/- 2.48) in >= 65 years group with no statistically significant difference. (p=0.825). In conclusion, there was no significant difference in terms of the number of collected CD34-positive stem cells in this study that investigates the mobilization data, procedure and product kinetics, we think that successful stem cell mobilization can be performed in appropriately selected patients regardless of age. (C) 2018 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.transci.2018.01.010
dc.identifier.endpage207en_US
dc.identifier.issn1473-0502
dc.identifier.issn1878-1683
dc.identifier.issue2en_US
dc.identifier.pmid29439920en_US
dc.identifier.scopus2-s2.0-85044648610en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage204en_US
dc.identifier.urihttps://doi.org/10.1016/j.transci.2018.01.010
dc.identifier.urihttps://hdl.handle.net/11616/98220
dc.identifier.volume57en_US
dc.identifier.wosWOS:000436914800016en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofTransfusion and Apheresis Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMultiple myelomaen_US
dc.subjectMobilizationen_US
dc.subjectApheresisen_US
dc.titleStem cell mobilization kinetics in elderly patients with multiple myelomaen_US
dc.typeArticleen_US

Dosyalar